$0.5584
0.03536.75%
Dern. MÀJ: Oct 29, 1:47 PM
Kairos Pharma (KAPA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-4.41 | $-3.43 | $-1.47 | $-4.41 |
| Actual | $-2.94 | $-3.92 | $-3.43 | $-3.43 |
| Surprise | +33.3% | -14.3% | -133.3% | +22.2% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.63 | $-0.77 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-2.94 | $-4.41 | 33.3 % |
| Q1 | May 13, 2026 | $-3.92 | $-3.43 | -14.3 % |
| Q4 | Mar 31, 2026 | $-3.43 | $-1.47 | -133.3 % |
| Q3 | Nov 14, 2025 | $-3.43 | $-4.41 | 22.2 % |